Royal Bank of Canada’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-462
| Closed | -$9K | – | 6551 |
|
|
2023
Q3 | $9K | Sell |
462
-13,545
| -97% | -$264K | ﹤0.01% | 5944 |
|
|
2023
Q2 | $336K | Sell |
14,007
-4,589
| -25% | -$110K | ﹤0.01% | 3868 |
|
|
2023
Q1 | $408K | Sell |
18,596
-22,501
| -55% | -$494K | ﹤0.01% | 3687 |
|
|
2022
Q4 | $1.03M | Sell |
41,097
-2,727
| -6% | -$68.1K | ﹤0.01% | 3078 |
|
|
2022
Q3 | $1.08M | Sell |
43,824
-34,566
| -44% | -$849K | ﹤0.01% | 2971 |
|
|
2022
Q2 | $1.69M | Sell |
78,390
-6,908
| -8% | -$149K | ﹤0.01% | 2673 |
|
|
2022
Q1 | $2.38M | Sell |
85,298
-9,433
| -10% | -$264K | ﹤0.01% | 2532 |
|
|
2021
Q4 | $3.65M | Sell |
94,731
-15,645
| -14% | -$603K | ﹤0.01% | 2242 |
|
|
2021
Q3 | $5.05M | Buy |
110,376
+5,334
| +5% | +$244K | ﹤0.01% | 1983 |
|
|
2021
Q2 | $5.25M | Buy |
105,042
+15,629
| +17% | +$781K | ﹤0.01% | 2026 |
|
|
2021
Q1 | $4.59M | Sell |
89,413
-5,706
| -6% | -$293K | ﹤0.01% | 2019 |
|
|
2020
Q4 | $4.72M | Buy |
95,119
+3,401
| +4% | +$169K | ﹤0.01% | 1922 |
|
|
2020
Q3 | $3.58M | Sell |
91,718
-832
| -0.9% | -$32.4K | ﹤0.01% | 1935 |
|
|
2020
Q2 | $4M | Sell |
92,550
-56,251
| -38% | -$2.43M | ﹤0.01% | 1848 |
|
|
2020
Q1 | $4.36M | Buy |
148,801
+31,870
| +27% | +$934K | ﹤0.01% | 1652 |
|
|
2019
Q4 | $4.45M | Sell |
116,931
-31,495
| -21% | -$1.2M | ﹤0.01% | 1879 |
|
|
2019
Q3 | $3.54M | Buy |
148,426
+31,709
| +27% | +$755K | ﹤0.01% | 1955 |
|
|
2019
Q2 | $3.36M | Buy |
116,717
+18,757
| +19% | +$540K | ﹤0.01% | 1996 |
|
|
2019
Q1 | $2.79M | Buy |
97,960
+20,798
| +27% | +$592K | ﹤0.01% | 2062 |
|
|
2018
Q4 | $1.79M | Buy |
77,162
+18,406
| +31% | +$427K | ﹤0.01% | 2259 |
|
|
2018
Q3 | $2.03M | Buy |
58,756
+4,200
| +8% | +$145K | ﹤0.01% | 2367 |
|
|
2018
Q2 | $1.78M | Buy |
54,556
+1,938
| +4% | +$63.4K | ﹤0.01% | 2360 |
|
|
2018
Q1 | $1.73M | Buy |
52,618
+7,678
| +17% | +$252K | ﹤0.01% | 2310 |
|
|
2017
Q4 | $1.28M | Buy |
44,940
+17,037
| +61% | +$484K | ﹤0.01% | 2492 |
|
|
2017
Q3 | $813K | Buy |
27,903
+2,079
| +8% | +$60.6K | ﹤0.01% | 2791 |
|
|
2017
Q2 | $620K | Buy |
25,824
+3,969
| +18% | +$95.3K | ﹤0.01% | 2892 |
|
|
2017
Q1 | $507K | Sell |
21,855
-15,728
| -42% | -$365K | ﹤0.01% | 3058 |
|
|
2016
Q4 | $692K | Buy |
37,583
+23,534
| +168% | +$433K | ﹤0.01% | 2817 |
|
|
2016
Q3 | $318K | Buy |
14,049
+3,493
| +33% | +$79.1K | ﹤0.01% | 3394 |
|
|
2016
Q2 | $190K | Buy |
10,556
+8,601
| +440% | +$155K | ﹤0.01% | 3776 |
|
|
2016
Q1 | $37K | Buy |
1,955
+1,080
| +123% | +$20.4K | ﹤0.01% | 4568 |
|
|
2015
Q4 | $25K | Buy |
875
+184
| +27% | +$5.26K | ﹤0.01% | 4864 |
|
|
2015
Q3 | $18K | Buy |
+691
| New | +$18K | ﹤0.01% | 5010 |
|